Insider · CIK 0001866171
Neha Krishnamohan
cfoofficerdirector
Files at ARQT (Arcutis Biotherapeutics, Inc.), ARTV (Artiva Biotherapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 15, 2025 | ARTV Artiva Biotherapeutics, Inc. | FTax withholding Common Stock | -1,341 | $2.13 | $2,856 | 108,659 | Aug 18, 2025 |
| Aug 15, 2025 | ARTV Artiva Biotherapeutics, Inc. | FTax withholding Common Stock | -5,813 | $2.75 | $16k | 102,846 | Aug 18, 2025 |
| Jun 12, 2025 | ARQT Arcutis Biotherapeutics, Inc. | AGrant or award Common Stock | +7,609 | $0.00 | $0 | 23,355 | Jun 16, 2025 |
| Jun 12, 2025 | ARQT Arcutis Biotherapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +20,568 | $0.00 | $0 | 20,568 | Jun 16, 2025 |
| Feb 26, 2025 | ARTV Artiva Biotherapeutics, Inc. | AGrant or award Common Stock | +60,000 | $0.00 | $0 | 110,000 | Feb 28, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.